TEVA•benzinga•
Teva Pharmaceutical Indus Q1 Adj. EPS $0.55, Inline, Sales $3.66B Miss $3.75B Estimate
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 3, 2022 by benzinga